VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BMRN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BMRNBioMarin Pharmaceutical Inc.
$60.35$11.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBMRNQuarterly Financials

BioMarin Pharmaceutical Inc. (BMRN) Quarterly Financials

120+ quarters historyFree accessUpdated daily

BioMarin Pharmaceutical Inc. (BMRN) quarterly income statement — complete revenue, gross profit & net income history

BMRN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue766.21M874.57M776.13M825.41M745.14M747.31M745.74M712.03M648.83M646.21M581.33M595.27M596.41M537.54M505.34M533.8M519.36M449.81M408.74M501.69M
Revenue Growth %2.83%17.03%4.08%15.92%14.84%15.65%28.28%19.61%8.79%20.22%15.04%11.52%14.84%19.5%23.63%6.4%6.86%-0.51%-14.27%16.81%
Cost of Goods Sold195M295.1M140.09M150.09M151.56M136.14M188.46M130.46M125.18M135.48M128.04M130.62M135.47M127.29M116.29M123.13M116.97M119.75M103.54M127.06M
COGS % of Revenue25.45%33.74%18.05%18.18%20.34%18.22%25.27%18.32%19.29%20.97%22.03%21.94%22.71%23.68%23.01%23.07%22.52%26.62%25.33%25.33%
Gross Profit571.21M579.47M636.05M675.32M593.59M611.17M557.28M581.57M523.65M510.73M453.29M464.66M460.94M410.25M389.06M410.67M402.39M330.06M305.2M374.63M
Gross Margin %74.55%66.26%81.95%81.82%79.66%81.78%74.73%81.68%80.71%79.03%77.97%78.06%77.29%76.32%76.99%76.93%77.48%73.38%74.67%74.67%
Gross Profit Growth %-3.77%-5.19%14.13%16.12%13.36%19.67%22.94%25.16%13.6%24.49%16.51%13.15%14.55%24.3%27.47%9.62%9.98%1.25%5.98%13%
Operating Expenses441.57M500.08M682.74M398.43M369.69M449.77M443.39M461.12M435.19M496.51M422.76M399.09M398.54M434.75M391.47M371.52M265.07M395.94M358.42M362.96M
OpEx % of Revenue57.63%57.18%87.97%48.27%49.61%60.18%59.46%64.76%67.07%76.83%72.72%67.04%66.82%80.88%77.47%69.6%51.04%88.02%87.69%72.35%
Selling, General & Admin258.29M802.12M268.42M232.3M206.1M266.6M253.5M263M225.9M275M172.6M206.1M211.02M245.71M216.8M196.84M194.62M217.6M183.3M184.2M
SG&A % of Revenue33.71%91.72%34.58%28.14%27.66%35.67%33.99%36.94%34.82%42.56%29.69%34.62%35.38%45.71%42.9%36.87%37.47%48.38%44.84%36.72%
Research & Development178.8M192.41M409.48M161.31M158.73M173.51M184.9M183.79M204.99M206.25M191.31M177.36M171.85M172.75M157.83M158.19M160.84M161.09M157.87M161.11M
R&D % of Revenue23.34%22%52.76%19.54%21.3%23.22%24.79%25.81%31.59%31.92%32.91%29.8%28.81%32.14%31.23%29.63%30.97%35.81%38.62%32.11%
Other Operating Expenses1000K-1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K-1000K1000K1000K1000K
Operating Income137.64M79.39M-46.69M276.89M223.89M161.41M113.89M120.45M88.46M14.22M30.52M65.57M62.4M-24.5M-2.42M39.15M137.33M-65.88M-53.22M11.67M
Operating Margin %17.96%9.08%-6.02%33.55%30.05%21.6%15.27%16.92%13.63%2.2%5.25%11.01%10.46%-4.56%-0.48%7.33%26.44%-14.65%-13.02%2.33%
Operating Income Growth %-38.52%-50.81%-141%129.87%153.1%1035.15%273.11%83.71%41.76%158.04%1362.93%67.47%-54.56%62.81%95.46%235.44%447.42%-46.92%4.87%128.51%
EBITDA154.05M99.83M-28.2M295.45M245.96M185.01M132.9M146.91M115.81M41.08M56.21M90.98M88.83M53K22.39M64.42M164.67M-39.89M-26.38M38.9M
EBITDA Margin %20.11%11.41%-3.63%35.79%33.01%24.76%17.82%20.63%17.85%6.36%9.67%15.28%14.89%0.01%4.43%12.07%31.71%-8.87%-6.45%7.75%
EBITDA Growth %-37.37%-46.04%-121.22%101.1%112.38%350.37%136.43%61.47%30.38%77409.43%151.11%41.23%-46.06%100.13%184.86%65.6%210.29%-128.2%9.99%347.33%
D&A (Non-Cash Add-back)16.41M20.44M18.49M18.56M22.07M23.61M19.01M26.46M27.35M26.86M25.68M25.42M26.42M24.55M24.8M25.27M27.34M25.99M26.84M27.23M
EBIT137.64M-24.38M-23.75M300.55M240.95M171.89M137.41M135.71M109.09M24.83M45.45M74.56M60.46M-14.53M2.77M38.71M137.99M-63.32M-42.29M17.97M
Net Interest Income7.6M16.43M15.28M16.15M16.15M15.04M15.09M16.21M15.82M11.95M11.96M8.86M8.24M5.08M320K-1.35M-1.99M-2.1M-2.04M654K
Interest Income22.56M19.21M17.85M18.83M19.01M17.68M18.05M19.79M19.36M18.04M15.74M12.61M11.94M8.71M5M2.5M1.82M1.75M1.83M4.47M
Interest Expense14.96M2.78M2.58M2.68M2.86M2.58M2.97M3.57M3.55M6.1M3.78M3.75M3.7M3.63M4.68M3.86M3.81M3.85M3.87M3.82M
Other Income/Expense11.56M-106.54M20.37M20.98M14.2M8.23M20.55M11.68M17.09M5.11M11.14M5.24M-5.65M6.94M513K-4.3M-3.14M-694K7.06M2.48M
Pretax Income141.2M-27.15M-26.32M297.87M238.09M169.64M134.44M132.14M105.55M19.33M41.67M70.81M56.76M-17.56M-1.9M34.85M134.19M-66.57M-46.16M14.16M
Pretax Margin %18.43%-3.1%-3.39%36.09%31.95%22.7%18.03%18.56%16.27%2.99%7.17%11.9%9.52%-3.27%-0.38%6.53%25.84%-14.8%-11.29%2.82%
Income Tax35.68M19.42M4.42M57.34M52.4M44.7M28.36M24.96M16.89M-1.05M1.29M14.77M5.91M-17.31M4.75M7.19M13.39M-8.68M-9.67M1.22M
Effective Tax Rate %25.27%-71.52%-16.79%19.25%22.01%26.35%21.1%18.89%16%-5.42%3.1%20.86%10.4%98.58%-249.37%20.62%9.98%13.03%20.94%8.58%
Net Income105.53M-46.57M-30.74M240.53M185.69M124.94M106.08M107.17M88.66M20.38M40.38M56.04M50.85M-249K-6.65M27.66M120.8M-57.9M-36.49M12.94M
Net Margin %13.77%-5.33%-3.96%29.14%24.92%16.72%14.22%15.05%13.66%3.15%6.95%9.41%8.53%-0.05%-1.32%5.18%23.26%-12.87%-8.93%2.58%
Net Income Growth %-43.17%-137.28%-128.98%124.43%109.43%513.22%162.72%91.25%74.35%8282.73%707.01%102.57%-57.9%99.57%81.77%113.77%595.4%-361.99%-104.65%144.34%
Net Income (Continuing)105.53M-46.57M-30.74M240.53M185.69M124.94M106.08M107.17M88.66M20.38M40.38M56.04M50.85M-249K-6.65M27.66M120.8M-57.9M-36.49M12.94M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.54-0.22-0.161.230.950.640.550.550.460.110.210.290.26-0.00-0.040.150.62-0.32-0.200.07
EPS Growth %-43.16%-134.38%-129.09%123.64%106.52%481.82%161.9%89.66%76.92%-686.59%93.33%-58.06%99.59%82.1%114.29%588.89%-366.67%-104.99%143.75%
EPS (Basic)0.55-0.24-0.161.250.970.660.570.560.470.110.210.300.27-0.00-0.040.150.63-0.32-0.200.07
Diluted Shares Outstanding197.67M197.39M192.03M196.64M196.47M196.58M197.15M200.5M199.26M191.84M191.17M195M194.36M186.03M185.6M187.45M194.89M183.55M183.21M185.43M
Basic Shares Outstanding192.5M191.79M192.03M191.44M190.97M190.69M190.43M190.11M188.87M188.48M188.22M187.95M186.67M186.03M185.6M185.25M190.53M181.6M182.47M182.84M
Dividend Payout Ratio--------------------